RISING health care costs could lead to tighter government price controls, a Fitch Group unit said, creating headwinds for pharmaceutical companies and speeding up a shift toward cheaper generics. “The ...

Indian drugmaker Dr Reddy’s Laboratories hopes to launch a generic version of Novo Nordisk’s blockbuster weight-loss drug ‌Wegovy at a competitive price that could be up to 60% lower than the branded ...

In a significant patent skirmish for the Australian biotech and pharmaceutical sector, AstraZeneca PLC (LSE:AZN, NASDAQ:AZN) has secured a Federal Court ruling that blocks local generics maker ...

Zydus and its wholly owned US subsidiary will pay Astellas a total of 120 million dollars under the terms of the agreement disclosed on February 12, 2026. The settlement ends all litigation between ...

Java Development Kit (JDK) 26, a planned update to standard Java due March 17, 2026, has reached its second release candidate (RC) stage. The RC is open for critical bug fixes, with the feature set ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

Sam Chun Dang Pharm said on the 26th that it signed a definitive agreement for an exclusive license and commercialization of an oral GLP-1 class generic in 11 countries, including the United Kingdom, ...

Lupin Ltd. posted a 37.4 per cent year-on-year (YoY) jump in quarterly net profit to Rs. 1,180.5 crore in Q3 FY26, driven primarily by record US sales, stronger gross margins, and a favourable product ...

Novo Nordisk CEO Mike Doustdar has a plan to steer the company through what’s been described as a “show me” year. The Danish drugmaker kicked off 2026 with its explosive obesity pill launch, but ...

Back in 2024, not long after laying off five percent of the company’s workforce, EA CEO Andrew Wilson got on a stage to wax poetic about all the ways generative AI would help take the gaming industry ...

HYDERABAD, Feb 17 (Reuters) - Indian drugmaker Dr Reddy’s Laboratories (REDY.NS), opens new tab hopes to launch a generic version of Novo Nordisk’s (NOVOb.CO), opens new tab blockbuster weight‑loss ...